Cyclotek Pty Ltd logo

Cyclotek Pty Ltd

Improving patient outcomes with accessible targeted radiopharmaceuticals.

106 employees · est. 2001 · Australia

VS
RayzeBio logo

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 employees · est. 2020 · San Diego, United States

Cyclotek Pty Ltd is the older company (2001 vs 2020); RayzeBio is the larger of the two.

Side-by-Side Comparison

Cyclotek Pty Ltd RayzeBio
Founded
2001 older 2020
Headquarters
Australia San Diego, United States
Employees
106 258 larger
Industry
Health Care, Logistics, Manufacturing Biotechnology, Health Care, Medical Devices
Funding Stage
Private Equity Acquired
Total Funding
Not tracked yet $4.78B
Funding Rounds
1 5
Services
Not tracked yet Development of radiopharmaceutical therapies, Precision cancer treatment using actinium-225, Manufacturing of pharmaceutical products, Clinical trial capabilities, Drug discovery and development
Target Customers
Not tracked yet Cancer patients, Oncologists, Healthcare providers, Research institutions, Pharmaceutical companies
Taxonomy
Radiopharmaceuticals, PET-tracers, Oncology, Neurology, Personalized Medicine, Patient Outcomes, Diagnostic Imaging, Therapeutic Discovery, Genomics, Healthcare Innovation Radiopharmaceuticals, Cancer Treatment, Targeted Therapies, Radioisotopes, Alpha Particles, Actinium-225, Oncology Drug Development, Pipeline Development, Bristol Myers Squibb, Innovative Cancer Solutions, Radiopharmaceutical Leadership, Patient Outcomes, Clinical Advancement, Cancer Treatment Revolution
Website
cyclotek.com rayzebio.com
Cyclotek Pty Ltd logo

About Cyclotek Pty Ltd

Cyclotek Pty Ltd, established in 2001, is a leading radiopharmaceutical manufacturer based in Australia and New Zealand, dedicated to enhancing patient outcomes with accessible targeted radiopharmaceuticals. The company's mission revolves around offering novel PET-tracers that deliver patient-specif...

RayzeBio logo

About RayzeBio

RayzeBio, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical sectors, focusing on the development of targeted innovative radiopharmaceuticals for cancer treatment. With a mission outlined in their slogan, "Targeted innovative radiopharmaceuticals for cancer," RayzeBio...

We will tell you when either one moves

BounceWatch watches Cyclotek Pty Ltd and RayzeBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cyclotek Pty Ltd and RayzeBio — by email.

Frequently Asked Questions

Cyclotek Pty Ltd — Improving patient outcomes with accessible targeted radiopharmaceuticals.. RayzeBio — Targeted innovative radiopharmaceuticals for cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cyclotek Pty Ltd has raised undisclosed funding while RayzeBio has raised $4.78B.
Cyclotek Pty Ltd and RayzeBio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cyclotek Pty Ltd with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cyclotek Pty Ltd on 12 Sep 2024, and RayzeBio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy